Results
ORIGINS
The ERIS team is happy to announce that Prof. Dr. Wendy Van den Broeck and Mr. Simon Delaere have been awarded ORIGINS project under HORIZON-CL4-2025-03 call.
Read more
FTI Brussel
Practical info
16 October 2026 00:00
-
20 October 2026 00:00
Join us at FTI Brussel, where VUB scientists will open the doors to their labs, take you on tech walks, join panel discussions, and showcase their work through exhibitions and live demonstrations.
Read more
INTELLICROPS
Read more
VUB opens its labs for FTI Brussels
VUB is a structural partner of the FTI Festival in Brussels. From tours on the Etterbeek campus to visits at research centres on the outskirts of Brussels, get a unique behind-the-scenes look at research that is helping shape the future.
Read more
Annual Report 2025 of the Vice-rectorate Innovation & Industry Relations
Discover the real-world impact of VUB's innovative research in 2025 with our newly released Annual Report 2025. From new spin-offs to impactful industry collaborations, check out the full report for all the details.
Read more
InterACT programme seeks expressions of interest from Belgian non-academic organisations
InterACT is a postdoctoral research and training programme, designed to help researchers translate scientific knowledge into meaningful societal and policy-relevant impact. Express your interest to host a researcher at your organisation without any costs.
Read more
Aurora niPCT™ test aims to shorten time to pregnancy in IVF
A groundbreaking diagnostic test developed by Fertiga—a spin-off of UZ Brussel and Vrije Universiteit Brussel (VUB)—could soon help women undergoing IVF treatment get pregnant faster.
Read more
Confo Therapeutics announces promising results for new weight-loss surgery complication treatment
Confo Therapeutics, a biotechnology company and spin-off from VUB and VIB, has shared encouraging new results for a drug candidate designed to treat a serious complication of weight-loss surgery.
Read more
ETHERNA
Read more
KONLIGO
Read more